Published in Cold Spring Harb Perspect Med on May 01, 2015
Plant-based vaccines for animals and humans: recent advances in technology and clinical trials. Ther Adv Vaccines (2015) 0.81
The 50 Most-cited Articles in Gastroenterology and Hepatology from Mainland China. Pak J Med Sci (2017) 0.75
Identification of acetyltransferase genes (HAT1 and KAT8) regulating HBV replication by RNAi screening. Cell Biosci (2015) 0.75
Immune Responses to Single-Dose Versus Double-Dose Hepatitis B Vaccines in Healthcare Workers not Responding to the Primary Vaccine Series: A Randomized Clinical Trial. Hepat Mon (2016) 0.75
Engineering Hepadnaviruses as Reporter-Expressing Vectors: Recent Progress and Future Perspectives. Viruses (2016) 0.75
The declining rates of hepatitis B carriage among adolescents and young people in the Eastern region of Saudi Arabia. Saudi Med J (2016) 0.75
Global cancer statistics. CA Cancer J Clin (2011) 185.92
Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 56.72
Chronic hepatitis B: update 2009. Hepatology (2009) 16.08
Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures. J Viral Hepat (2004) 13.18
Global epidemiology of hepatitis C virus infection: new estimates of age-specific antibody to HCV seroprevalence. Hepatology (2013) 12.46
Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level. JAMA (2006) 10.58
Epidemiology of viral hepatitis and hepatocellular carcinoma. Gastroenterology (2012) 10.00
Predicting cirrhosis risk based on the level of circulating hepatitis B viral load. Gastroenterology (2006) 6.67
Epidemiological serosurvey of hepatitis B in China--declining HBV prevalence due to hepatitis B vaccination. Vaccine (2009) 6.30
Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: results of systematic reviews. Lancet (2011) 6.21
A "NEW" ANTIGEN IN LEUKEMIA SERA. JAMA (1965) 6.21
Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. Taiwan Childhood Hepatoma Study Group. N Engl J Med (1997) 6.03
Recommendations for identification and public health management of persons with chronic hepatitis B virus infection. MMWR Recomm Rep (2008) 6.02
Global epidemiology of hepatitis B virus infection: new estimates of age-specific HBsAg seroprevalence and endemicity. Vaccine (2012) 6.01
Natural history of chronic hepatitis B: special emphasis on disease progression and prognostic factors. J Hepatol (2007) 4.73
A mathematical model to estimate global hepatitis B disease burden and vaccination impact. Int J Epidemiol (2005) 4.48
Causes of death after diagnosis of hepatitis B or hepatitis C infection: a large community-based linkage study. Lancet (2006) 4.45
Decreased incidence of hepatocellular carcinoma in hepatitis B vaccinees: a 20-year follow-up study. J Natl Cancer Inst (2009) 3.19
Prevalence of chronic hepatitis B among foreign-born persons living in the United States by country of origin. Hepatology (2012) 3.13
Hepatitis B virus infection. Lancet (2014) 2.78
A meta-analysis of epidemiological studies on the combined effect of hepatitis B and C virus infections in causing hepatocellular carcinoma. Int J Cancer (1998) 2.64
Hepatitis B virus genotypes. Vaccine (2005) 2.56
Update on diagnosis, management, and prevention of hepatitis B virus infection. Clin Microbiol Rev (1999) 2.55
Hepatitis B and human immunodeficiency virus coinfection. Hepatology (2009) 2.50
Epidemiology of hepatocellular carcinoma in the United States: where are we? Where do we go? Hepatology (2014) 2.34
Hepatitis delta virus. Lancet (2011) 2.32
Nonhospital health care-associated hepatitis B and C virus transmission: United States, 1998-2008. Ann Intern Med (2009) 2.28
Hepatitis B-related hepatocellular carcinoma: epidemiological characteristics and disease burden. J Viral Hepat (2009) 2.18
The influence of age on the development of the hepatitis B carrier state. Proc Biol Sci (1993) 2.12
Incidence of hepatocellular carcinoma in chronic hepatitis B patients receiving nucleos(t)ide therapy: a systematic review. J Hepatol (2010) 1.93
The influence of hepatitis B virus genotype and subgenotype on the natural history of chronic hepatitis B. Hepatol Int (2008) 1.77
A meta-analysis of case-control studies on the combined effect of hepatitis B and C virus infections in causing hepatocellular carcinoma in China. Br J Cancer (2005) 1.76
Hepatitis D virus infection--not a vanishing disease in Europe! Hepatology (2007) 1.68
The New Zealand Hepatitis B Screening Programme: screening coverage and prevalence of chronic hepatitis B infection. N Z Med J (2005) 1.67
Changes in serum levels of HBV DNA and alanine aminotransferase determine risk for hepatocellular carcinoma. Gastroenterology (2011) 1.59
Relationship of genotypes of hepatitis B virus to mutations, disease progression and response to antiviral therapy. J Viral Hepat (2005) 1.59
20 years into the Gambia Hepatitis Intervention Study: assessment of initial hypotheses and prospects for evaluation of protective effectiveness against liver cancer. Cancer Epidemiol Biomarkers Prev (2008) 1.44
Management of hepatic complications in HIV-infected persons. J Infect Dis (2008) 1.42
Incidence and routes of transmission of hepatitis B virus in England and Wales, 1995-2000: implications for immunisation policy. J Clin Virol (2004) 1.41
Hepatitis D: thirty years after. J Hepatol (2009) 1.41
Sytematic review and meta-analysis of prevalence of hepatitis B in India. Indian Pediatr (2007) 1.38
Epidemiology of hepatitis B infection in the Western Pacific and South East Asia. Gut (1996) 1.38
HIV-HBV coinfection--a global challenge. N Engl J Med (2012) 1.36
Epidemiology of acute and chronic hepatitis B and delta over the last 5 decades in Italy. World J Gastroenterol (2014) 1.36
Chronic hepatitis D: a vanishing Disease? An Italian multicenter study. Hepatology (2000) 1.34
Epidemiological and clinical burden of chronic hepatitis B virus/hepatitis C virus infection. A multicenter Italian study. J Hepatol (2003) 1.32
Hepatitis B virus and HIV coinfection in low-income countries: unmet needs. Clin Infect Dis (2008) 1.23
Coinfection of hepatitis B and C viruses and risk of hepatocellular carcinoma: systematic review and meta-analysis. Int J Cancer (2011) 1.21
High impact of migration on the prevalence of chronic hepatitis B in the Netherlands. Eur J Gastroenterol Hepatol (2008) 1.08
High prevalence of hepatitis B virus and hepatitis D virus in the western Brazilian Amazon. Am J Trop Med Hyg (2005) 1.07
The burden of chronic hepatitis B virus infection in Australia, 2011. Aust N Z J Public Health (2013) 1.07
Elimination of new chronic hepatitis B virus infections: results of the Alaska immunization program. J Infect Dis (2000) 1.06
Re-emerging interest in hepatitis delta: new insights into the dynamic interplay between HBV and HDV. J Hepatol (2010) 1.04
Epidemiology of hepatitis C virus infection in highly endemic HBV areas in China. PLoS One (2013) 1.01
Control of hepatocellular carcinoma through hepatitis B vaccination in areas of high endemicity: perspectives for global liver cancer prevention. Cancer Lett (2009) 0.98
Should chronic hepatitis B mothers breastfeed? a meta analysis. BMC Public Health (2011) 0.98
Mortality due to viral hepatitis in the Global Burden of Disease Study 2010: new evidence of an urgent global public health priority demanding action. Antivir Ther (2013) 0.95
Viral hepatitis in resource-limited countries and access to antiviral therapies: current and future challenges. Future Virol (2013) 0.94
Antiviral therapies and prospects for a cure of chronic hepatitis B. Cold Spring Harb Perspect Med (2015) 0.93
Molecular epidemiology of hepatitis B in the Indigenous people of northern Australia. J Gastroenterol Hepatol (2013) 0.93
Liver cancer is the fastest increasing cause of cancer death in Australians. Med J Aust (2012) 0.91
Implementing a birth dose of hepatitis B vaccine for home deliveries in Africa--too soon? Vaccine (2010) 0.90
Hepatitis delta virus as a global health problem. Vaccine (1990) 0.90
An outbreak of hepatitis B with high mortality in India: association with precore, basal core promoter mutants and improperly sterilized syringes. J Viral Hepat (2010) 0.88
Hepatitis B virus genotypes and variants. Cold Spring Harb Perspect Med (2015) 0.86
Chronic hepatitis B prevalence among Aboriginal and Torres Strait Islander Australians since universal vaccination: a systematic review and meta-analysis. BMC Infect Dis (2013) 0.83
The timing of hepatitis B virus (HBV) immunization relative to human immunodeficiency virus (HIV) diagnosis and the risk of HBV infection following HIV diagnosis. Am J Epidemiol (2010) 0.82
Hepatitis D virus in Victoria 2000-2009. Intern Med J (2013) 0.80
Multiplicative synergistic risk of hepatocellular carcinoma development among hepatitis B and C co-infected subjects in HBV endemic area: a community-based cohort study. BMC Cancer (2012) 0.80
Do hepatitis B virus and hepatitis C virus co-infections increase hepatocellular carcinoma occurrence through synergistically modulating lipogenic gene expression? Hepatol Res (2012) 0.79
Immune Response in Hepatitis B Virus Infection. Cold Spring Harb Perspect Med (2015) 0.77